邦特

-1.00 (-0.88%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

112.0072成交張數13.16本益比2.20股價淨值比4.91%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	49	35	27.7%	2.75	50.91	17.3%	12.2%	1.3	1.2
2026Q1	48	34	29.7%	2.53	48.77	16.6%	11.5%	2.5	2.1
2025Q4	47	36	22.6%	4.27	52.05	15.3%	11.6%	2.1	2.0
2025Q3	45	34	23.5%	4.11	49.57	15.4%	11.5%	1.2	1.1
2025Q2	47	33	30.7%	2.70	47.48	16.3%	10.9%	1.3	1.2
2025Q1	48	32	32.2%	2.51	46.71	17.2%	11.3%	2.1	2.0
2024Q4	46	34	25.9%	3.92	49.65	15.9%	11.4%	2.3	2.8
2024Q3	45	33	26.8%	3.88	47.45	15.6%	11.1%	1.3	1.2
2024Q2	48	32	34.8%	2.43	45.53	16.5%	10.7%	1.6	0.9
2024Q1	48	30	36.3%	2.35	43.66	16.4%	10.3%	1.8	1.7
2023Q4	46	32	31.0%	3.35	46.03	14.5%	10.0%	2.4	2.4
2023Q3	45	31	31.2%	3.17	44.65	15.3%	10.5%	2.2	2.2
2023Q2	46	29	36.1%	2.47	42.27	15.7%	10.3%	0.7	0.6
2023Q1	45	28	37.6%	2.35	40.63	17.3%	11.1%	1.5	1.4
2022Q4	45	30	32.3%	3.34	43.75	16.9%	11.8%	2.9	2.7
2022Q3	43	29	31.4%	2.82	42.38	18.2%	12.9%	1.1	-0.6
2022Q2	41	28	32.9%	1.99	39.98	16.6%	11.7%	1.4	0.3
2022Q1	40	26	34.0%	2.09	37.94	16.0%	11.3%	1.0	-0.2
2021Q4	39	28	27.4%	3.27	40.45	15.8%	11.6%	1.7	-0.2
2021Q3	36	27	26.5%	4.06	38.59	17.3%	12.9%	1.0	0.2
2021Q2	38	29	25.5%	4.30	41.31	18.3%	13.7%	0.9	-1.3
2021Q1	37	28	24.8%	5.02	40.20	18.6%	14.8%	1.1	1.1
2020Q4	36	27	25.2%	4.89	38.45	19.0%	15.0%	2.3	1.2
2020Q3	34	25	24.7%	4.56	36.49	17.9%	14.0%	1.4	1.4
2020Q2	32	24	25.4%	2.94	34.88	18.4%	13.7%	1.6	1.5
2020Q1	31	26	15.5%	5.06	37.52	18.1%	15.2%	1.1	1.0
2019Q4	29	25	15.4%	4.98	35.90	19.3%	16.3%	1.8	1.4
2019Q3	29	24	18.5%	3.88	34.69	20.7%	16.9%	1.5	1.3
2019Q2	31	23	26.0%	2.72	33.06	20.8%	15.3%	0.9	0.8
2019Q1	29	24	16.8%	4.46	35.09	18.9%	15.5%	2.0	1.9
2018Q4	28	23	16.5%	4.38	33.39	18.2%	15.0%	1.7	1.6
2018Q3	27	22	18.1%	3.78	31.72	18.0%	14.6%	0.7	0.7
2018Q2	29	21	26.6%	2.63	30.35	18.7%	13.8%	1.0	0.9
2018Q1	27	22	18.8%	3.92	31.85	15.7%	12.8%	1.2	1.1
2017Q4	26	21	18.5%	4.01	30.83	14.4%	11.7%	1.2	1.1
2017Q3	25	21	18.9%	3.99	29.60	14.7%	11.8%	0.8	0.7
2017Q2	27	20	26.2%	2.78	28.31	14.8%	10.8%	0.7	0.7
2017Q1	26	21	18.4%	3.86	30.25	15.4%	12.2%	0.7	0.7
2016Q4	26	21	19.0%	3.69	29.98	–	–	1.2	0.4
2016Q3	25	20	20.7%	3.36	28.56	–	–	0.2	-0.0